Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy
BMC Microbiology · 2024
DOI: 10.1186/s12866-024-03692-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, 2024. Verfasst von Fangfang Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Eighth People's Hospital, No.8 Caobao Road, Xuhui District, Shanghai, 200235, P.R. China. Hauptthemen laut MEDLINE: Berberine, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Special project of integrated traditional and Western medicine in Shanghai General Hospital in China, the Key Discipline Construction Project of Shanghai Xuhui Health System.
Abstract (Originalsprache)
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is a significant public health problem. This study investigated the antimicrobial properties and mechanisms of berberine (BBR), a plant alkaloid, against MRSA, evaluating its potential to enhance antibiotic therapy. RESULTS: Berberine only demonstrated variable but significant inhibitory effects on 50 clinical MRSA strains. When combined with antibiotics, synergistic effects were observed only with amikacin in 6 of the 50 MRSA strains. BBR disrupted MRSA cell wall integrity, leading to leakage of cellular contents. Network pharmacology analysis revealed that BBR targets multiple pathways essential for bacterial survival. CONCLUSION: The study confirmed the potent antimicrobial activity of berberine against MRSA and its capability to act synergistically with traditional antibiotics. Berberine's impact on cell wall integrity and bacterial survival pathways highlights its potential as an adjunct therapy in MRSA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai Eighth People's Hospital, No.8 Caobao Road, Xuhui District, Shanghai, 200235, P.R. China.
- School of Medicine, Jiangsu University, Zhenjiang, 212001, Jiangsu, P.R. China.
- Department of Clinical Laboratory, Shanghai Eighth People's Hospital, No.8 Caobao Road, Xuhui District, Shanghai, 200235, P.R. China. wolei6610@126.com.
Förderung
- Special project of integrated traditional and Western medicine in Shanghai General Hospital in China
- the Key Discipline Construction Project of Shanghai Xuhui Health System
Zitieren
APA
Zhou, F., Gu, X., Wang, W., Lin, M., & Wang, L. (2024). Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy. BMC Microbiology. https://doi.org/10.1186/s12866-024-03692-9
Vancouver
Zhou F, Gu X, Wang W, Lin M, Wang L. Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy. BMC Microbiology. 2024. doi:10.1186/s12866-024-03692-9
BibTeX
@article{Zhou2024,
author = {Zhou, Fangfang and Gu, Xuemei and Wang, Wei and Lin, Ming and Wang, Lei},
title = {Advancements in MRSA treatment: the role of berberine in enhancing antibiotic therapy},
journal = {BMC Microbiology},
year = {2024},
doi = {10.1186/s12866-024-03692-9}
}
EUVIMED